Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

long-term condition

- PMLiVE

Opdivo approved via UK’s early drug access scheme

Bristol-Myers Squibb’s immunotherapy the first lung cancer drug approved by EAMS

- PMLiVE

Merck plans expanded filing for Emend this year

Nausea and vomiting therapy more effective than placebo in 1000-patient trial

Roche Basel Switzerland

Roche planning ocrelizumab filings in early 2016

Firm claims MS candidate outperformed Merck Serono’s Rebif in two phase III trials

Eli Lilly HQ

Lilly and Immunocore ink immunotherapy R&D deal

Firms will test new joint therapy in patients with melanoma

- PMLiVE

Sobi wins European approval for oral form of orphan drug Orfadin

Expandstreatment options for rare genetic disease HT-1

Can Cinderella save us?

Basilea’s novel antibiotic reaches UK market

Zevtera can be used against a range of infections including MRSA

Recipharm appoints new sales director

Amine Tahiri joins the CMO’s development services sales team

Novartis building

Novartis buys chronic pain specialist Spinifex Pharma

Pays $200m for the Australian pharmaceutical company

The future of communications is closer than you think

Ashfield Healthcare Communications on how the way physicians learn and keep up-to-date is changing

- PMLiVE

Are you happy now?

The problematic link between patient satisfaction and healthcare funding

- PMLiVE

Is telehealth delivering on its promises?

How well are new digital technologies being used to help patients see their doctors online

- PMLiVE

The role of pharma in the digital world of patient and doctors

AstraZeneca’s director of marketing Chris Boulton discusses the role of pharma when it comes to talking to patients and doctors

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links